Application of Bayesian Approach to Cost-Effectiveness Analysis of Antiviral Treatments in Chronic Hepatitis B.
Hepatitis B virus (HBV) infection is a major problem for public health; timely antiviral treatment can significantly prevent the progression of liver damage from HBV by slowing down or stopping the virus from reproducing. In the study we applied Bayesian approach to cost-effectiveness analysis, usin...
Main Authors: | Hua Zhang, Mingdong Huo, Jianqian Chao, Pei Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5004843?pdf=render |
Similar Items
-
Willing to Pay for Antiviral Treatment of Hepa¬titis B Patients
by: Hua ZHANG, et al.
Published: (2016-12-01) -
Health Care Utilization and Costs in Patients with Hepatitis B related Disease in Jiangsu, China
by: Hua Zhang, et al.
Published: (2015-02-01) -
How to compare antivirals in the treatment of chronic hepatitis B?
by: Leblebicioglu Hakan, et al.
Published: (2009-03-01) -
The Effectiveness of Antiviral Treatments for Patients with HBeAg-Positive Chronic Hepatitis B: A Bayesian Network Analysis
by: Zhang Hao, et al.
Published: (2018-01-01) -
Evolution of antiviral treatment chronic for hepatitis B, C and D
by: K. V. Zhdanov, et al.
Published: (2014-09-01)